Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
CRDL
#5404
Cardiol Therapeutics Inc. Class A Common Shares
1.0
2
-0.97%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
-0.97%
Changement Mensuel
+4.08%
Evolution sur 6 mois
-8.93%
Changement Annuel
-13.56%
Clôture Précédente
1.0
3
Open
1.0
2
Bid
Ask
Low
1.0
2
High
1.0
2
Volume
3
Marchés
Actions des Marchés US
Soins de Santé
CRDL
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
Q4, 24
TTM
Dividends per share
—
—
Dividend yield %
—
—
Payout ratio %
—
—
Nouvelles
카디올 테라퓨틱스, 2상 심근염 연구 결과 발표
Cardiol Therapeutics publishes phase II myocarditis study results
카디올 테라퓨틱스, 인수 계약 및 신주인수권 증서 계약서 제출
Cardiol Therapeutics files underwriting agreement and warrant indenture
카디올 테라퓨틱스, 1,350만 달러 규모 사모 발행 발표
Cardiol Therapeutics announces $13.5 million private placement
Cardiol Therapeutics, 167억 원 규모의 자금 조달 발표
Cardiol Therapeutics announces $13.5 million bought deal financing
Cardiol Therapeutics, 재발성 심낭염 임상시험 환자 등록 50% 달성
Cardiol Therapeutics reaches 50% enrollment in recurrent pericarditis trial
H.C. Wainwright, Cardiol Therapeutics에 ’매수’ 등급 재확인, 목표가 9달러
H.C. Wainwright reaffirms Buy rating on Cardiol Therapeutics stock at $9 target